Trade Rein Therapeutics Inc - ALRN CFD
Add to favourite- Summary
- Historical Data
Spread | 0.0936 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023679% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001457% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 0.01 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 1.6732 |
Open | 1.7932 |
1-Year Change | -69.64% |
Day's Range | 1.7632 - 1.7932 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 1, 2025 | 1.6732 | -0.1200 | -6.69% | 1.7932 | 1.9132 | 1.6732 |
Mar 31, 2025 | 1.7632 | 0.0200 | 1.15% | 1.7432 | 1.8932 | 1.7332 |
Mar 28, 2025 | 1.6832 | -0.0400 | -2.32% | 1.7232 | 1.7232 | 1.6732 |
Mar 27, 2025 | 1.7732 | 0.0000 | 0.00% | 1.7732 | 1.7732 | 1.7632 |
Mar 26, 2025 | 1.7132 | 0.0700 | 4.26% | 1.6432 | 1.7232 | 1.6432 |
Mar 25, 2025 | 1.6532 | -0.0800 | -4.62% | 1.7332 | 1.8132 | 1.6132 |
Mar 24, 2025 | 1.8632 | -0.0400 | -2.10% | 1.9032 | 1.9532 | 1.8432 |
Mar 21, 2025 | 1.8832 | -0.0100 | -0.53% | 1.8932 | 1.9032 | 1.8132 |
Mar 20, 2025 | 1.9032 | -0.0700 | -3.55% | 1.9732 | 1.9932 | 1.8832 |
Mar 19, 2025 | 1.9732 | 0.1300 | 7.05% | 1.8432 | 2.0432 | 1.8332 |
Mar 18, 2025 | 1.8432 | -0.0700 | -3.66% | 1.9132 | 1.9132 | 1.8432 |
Mar 17, 2025 | 2.0132 | 0.1200 | 6.34% | 1.8932 | 2.0132 | 1.8932 |
Mar 14, 2025 | 1.9932 | 0.0800 | 4.18% | 1.9132 | 2.0632 | 1.9132 |
Mar 13, 2025 | 1.9732 | 0.0300 | 1.54% | 1.9432 | 2.0132 | 1.8232 |
Mar 12, 2025 | 1.9332 | 0.0200 | 1.05% | 1.9132 | 2.0232 | 1.9132 |
Mar 11, 2025 | 1.9032 | 0.0500 | 2.70% | 1.8532 | 1.9532 | 1.7532 |
Mar 10, 2025 | 1.7032 | -0.2500 | -12.80% | 1.9532 | 1.9532 | 1.6332 |
Mar 7, 2025 | 1.9832 | 0.0100 | 0.51% | 1.9732 | 2.0232 | 1.9732 |
Mar 6, 2025 | 1.9632 | -0.0600 | -2.97% | 2.0232 | 2.0432 | 1.9632 |
Mar 5, 2025 | 2.0332 | -0.0100 | -0.49% | 2.0432 | 2.0532 | 1.9032 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Aileron Therapeutics, Inc. Company profile
About Aileron Therapeutics Inc
Aileron Therapeutics, Inc. is a clinical-stage chemoprotection oncology company. The Company is focused on transforming the experience of chemotherapy for cancer patients. It is developing ALRN-6924, which is their dual Mouse double minute 2 homolog (MDM2) and MDMX inhibitor to provide a single medicine to protect multiple healthy cell types throughout the body from chemotherapy while ensuring chemotherapy continues to destroy cancer cells. ALRN-6924 acts as an agent to reduce the toxic side effects of chemotherapy in the bone marrow of cancer patients without adversely impacting the anti-cancer activity of chemotherapy against p53-mutant tumors.
Financial summary
BRIEF: For the nine months ended 30 September 2021, Aileron Therapeutics Inc revenues was not reported. Net loss increased 20% to $19.4M. Higher net loss reflects Research and development increase of 38% to $12.1M (expense), Stock-based Compensation in SGA increase of 20% to $1.3M (expense), General and administrative increase of 1% to $6.1M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.51 to -$0.22.
Industry: | Bio Therapeutic Drugs |
285 Summer Street
Unit 101
BOSTON
MASSACHUSETTS 02210
US
News

Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com